Roles of differently polarized macrophages in the initiation and progressionof pancreatic cancer
P Storz - Frontiers in immunology, 2023 - frontiersin.org
During development of pancreatic cancer macrophage-mediated inflammatory processes
and the formation of cancerous lesions are tightly connected. Based on insight from mouse …
and the formation of cancerous lesions are tightly connected. Based on insight from mouse …
Tumor microenvironment interactions with cancer stem cells in pancreatic ductal adenocarcinoma
AM Palma, GG Bushnell, MS Wicha, R Gogna - Advances in cancer …, 2023 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer in
the United States. Additionally, the low survival rate makes PDAC the third-leading cause of …
the United States. Additionally, the low survival rate makes PDAC the third-leading cause of …
Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer
K Teramatsu, T Oono, K Oyama, N Fujimori… - BMC cancer, 2022 - Springer
Purpose The distribution of tissue infiltrating lymphocytes has been shown to affect the
prognosis of patients with pancreatic cancer in some previous studies. However, the role of …
prognosis of patients with pancreatic cancer in some previous studies. However, the role of …
Inflammatory cytokines and radiotherapy in pancreatic ductal adenocarcinoma
SSW Ng, LA Dawson - Biomedicines, 2022 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) remains a therapeutic challenge in clinical
oncology. Surgery is the only potentially curative treatment. However, the majority of PDAC …
oncology. Surgery is the only potentially curative treatment. However, the majority of PDAC …
Ribosomal protein S6 kinase 2 (RPS6KB2) is a potential immunotherapeutic target for cancer that upregulates proinflammatory cytokines
Q Ma, Y Yang, S Chen, H Cheng, P Gong… - Molecular Biology …, 2024 - Springer
Background Cancer is still a leading cause of mortality. Over the years, cancer therapy has
undergone significant advances driven by advancements in science and technology. A …
undergone significant advances driven by advancements in science and technology. A …
[CARTE][B] Pancreatic Cancer: Basic Mechanisms and Therapies
L Emdad, A Atfi, R Gogna, JG Trevino, PB Fisher - 2023 - books.google.com
Pancreatic Cancer: Basic Mechanisms and Therapies, Volume 159 in the Advances in
Cancer Research, presents the latest release in this ongoing, well-regarded serial with …
Cancer Research, presents the latest release in this ongoing, well-regarded serial with …
[PDF][PDF] Circulating CD8+ CD122+ T cells as a prognostic indicator of pancreatic cancer
寺松克人 - 2023 - catalog.lib.kyushu-u.ac.jp
Purpose: The distribution of tissue infiltrating lymphocytes has been shown to affect the
prognosis of patients with pancreatic cancer in some previous studies. However, the role of …
prognosis of patients with pancreatic cancer in some previous studies. However, the role of …
Identification of an Autophagy-Related Signature for Predicting Prognoses and Immune Activity in Pancreatic Cancer metastasis
Q Deng, L Wu, J He, F Wu, Z Jiang - 2022 - researchsquare.com
Background Although autophagy is crucial in cancer metastasis, the role of genes in the
autophagy process in pancreatic cancer metastasis and prognosis remains uncertain. The …
autophagy process in pancreatic cancer metastasis and prognosis remains uncertain. The …
Develo** a Predictive Model for Folfirinox Chemotherapy Response in Pancreatic Ductal Adenocarcinoma Using Conventional Circulating Biomarkers
GJ Strijk, J Lu, HW Wilmink, MYV Homs… - Available at SSRN … - papers.ssrn.com
Background FOLFIRINOX is the standard treatment for metastatic or locally advanced
pancreatic ductal adenocarcinoma (PDAC) and is also being tested as a neoadjuvant …
pancreatic ductal adenocarcinoma (PDAC) and is also being tested as a neoadjuvant …